Bayer CropScience to purchase Crompton´s share of Gustafson seed treatment business
Acquisition for 124 million US Dollar in North America and Mexico
Advertisement
Bayer CropScience LP in the U.S. and Bayer CropScience Inc. in Canada today signed agreements to purchase Crompton Corporation's (NYSE: CK) 50 percent share of the Gustafson seed treatment business in the United States, Canada and Mexico [NAFTA] for the purchase price of U.S.$124 million in cash. The action would give Bayer CropScience, which already holds a 50 percent share of the U.S. and Canadian Gustafson joint ventures, full ownership of Gustafson's NAFTA business, subject to customary closing conditions. The transaction is expected to close by the end of the first quarter.
Gustafson manufactures and markets seed treatment products and related equipment. Based in Plano, Texas, and Calgary, Canada, the company employs approximately 250 people in the NAFTA region. In 2003, Gustafson sales were approximately U.S.$130 million.
"Purchase of the Gustafson seed treatment business would allow us to participate directly in this increasingly important segment of the NAFTA crop protection markets," said Emil Lansu, President & CEO of Bayer CropScience LP and head of Bayer CropScience for the NAFTA region. According to Lansu, the acquisition would give Bayer CropScience the benefit of the full range of Gustafson's products, including certain products from third parties, which would continue to make up a key component of the Gustafson product portfolio.
"We presently have several strong seed treatment products," Lansu added. "With the Gustafson purchase we look to more fully realize the potential of this business while enhancing our ability to provide solutions for growers."
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Millipore Opens New State-of-the-Art Manufacturing Facility
Agreement concluded: Evonik’s collaboration with Unilever extended
J. Erik Fyrwald to be President and Chief Executive Officer of Univar - John J. Zillmer to become Executive Chairman of Univar and its Board of Directors
Natural mother of pearl structure, synthetic replication
Contract for propylene oxide plant based on Evonik-Uhde process for Chinese Province of Jilin

Maximizing Hydrogen Peroxide Formation during Water Electrolysis - Killing two birds with one stone

Scientists can predict and design single atom catalysts for important chemical reactions - Using fundamental calculations of molecular interactions, they created a catalyst with 100% selectivity in producing propylene
LION bioscience to Acquire Trega Biosciences
GCG MacVector to Support Mac OS X
Continuing strong growth for Viscotek in Europe
CSM subsidiary PURAC officially opens lactic acid factory in Thailand
